{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T23:05:24Z","timestamp":1784761524596,"version":"3.55.0"},"reference-count":16,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2024YFC2309600"],"award-info":[{"award-number":["2024YFC2309600"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009329","name":"Scientific Research and Technology Development Program of Guangxi Zhuang Autonomous Region","doi-asserted-by":"publisher","award":["2023AB22055"],"award-info":[{"award-number":["2023AB22055"]}],"id":[{"id":"10.13039\/501100009329","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Public Health"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.jiph.2025.102952","type":"journal-article","created":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T18:20:15Z","timestamp":1757096415000},"page":"102952","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Clinical characteristics analysis of anti-interferon-\u03b3 autoantibodies-associated adult-onset immunodeficiency with mycobacterium tuberculosis infection"],"prefix":"10.1016","volume":"18","author":[{"given":"Xuemei","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiangxiu","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siqiao","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanlin","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengchan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Limei","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaona","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ni","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyan","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Nong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyi","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.jiph.2025.102952_bib1","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1056\/NEJMoa1111160","article-title":"Adult-onset immunodeficiency in Thailand and Taiwan","volume":"367","author":"Browne","year":"2012","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.jiph.2025.102952_bib2","doi-asserted-by":"crossref","DOI":"10.1172\/JCI178263","article-title":"Neutralizing IFN-\u03b3 autoantibodies are rare and pathogenic in HLA-DRB1*15:02 or 16:02 individuals","volume":"134","author":"Peel","year":"2024","journal-title":"J Clin Investig"},{"issue":"2","key":"10.1016\/j.jiph.2025.102952_bib3","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1182\/blood-2003-04-1065","article-title":"Naturally occurring anti-IFN-gamma autoantibody and severe infections with mycobacterium cheloneae and burkholderia cocovenenans","volume":"103","author":"H\u00f6flich","year":"2004","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.jiph.2025.102952_bib4","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20190502","article-title":"Anti-IFN-\u03b3 autoantibodies underlie disseminated talaromyces marneffei infections","volume":"217","author":"Guo","year":"2020","journal-title":"J Exp Med"},{"issue":"8","key":"10.1016\/j.jiph.2025.102952_bib5","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1093\/cid\/cix996","article-title":"Clinical significance of Interferon-\u03b3 neutralizing autoantibodies against disseminated nontuberculous mycobacterial disease","volume":"66","author":"Aoki","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.jiph.2025.102952_bib6","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/S1473-3099(15)00089-4","article-title":"Host susceptibility to non-tuberculous mycobacterial infections","volume":"15","author":"Wu","year":"2015","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"10.1016\/j.jiph.2025.102952_bib7","doi-asserted-by":"crossref","DOI":"10.1080\/22221751.2024.2396887","article-title":"Clinical immunological characteristics of anti-interferon-\u03b3 autoantibodies syndrome: a 3 year prospective cohort study","volume":"13","author":"Liang","year":"2024","journal-title":"Emerg Microbes Infect"},{"issue":"12","key":"10.1016\/j.jiph.2025.102952_bib8","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1016\/j.cmi.2020.02.030","article-title":"Incorrect diagnoses in patients with neutralizing anti-interferon-gamma-autoantibodies","volume":"26","author":"Wu","year":"2020","journal-title":"Clin Microbiol Infect"},{"issue":"10481","key":"10.1016\/j.jiph.2025.102952_bib9","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/S0140-6736(24)02479-6","article-title":"Tuberculosis","volume":"405","author":"Trajman","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.jiph.2025.102952_bib10","unstructured":"Organization W.H. Global Tuberculosis Report 2024. Available at: \u3008https:\/\/wwwwhoint\/teams\/global-tuberculosis-programme\/TB-reports\/global-tuberculosis-report-2024\u3009. Accessed April 9, 2025."},{"issue":"2","key":"10.1016\/j.jiph.2025.102952_bib11","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1159\/000347112","article-title":"Reactive and infective dermatoses associated with adult-onset immunodeficiency due to anti-interferon-gamma autoantibody: sweet's syndrome and beyond","volume":"226","author":"Chan","year":"2013","journal-title":"Dermatology"},{"issue":"3","key":"10.1016\/j.jiph.2025.102952_bib12","article-title":"Talaromyces (Penicillium) marneffei infection in non-HIV-infected patients","volume":"5","author":"Chan","year":"2016","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.jiph.2025.102952_bib13","unstructured":"Chinese Center for Disease Control and Prevention. Technical Guidelines for Tuberculosis Control in China. \u3008https:\/\/wwwchinacdccn\/jkyj\/crb2\/yl\/fjh\/jswj_fjh\/202410\/P020241010432930570191pdf\u3009. 2021."},{"issue":"2","key":"10.1016\/j.jiph.2025.102952_bib14","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.cmi.2017.06.029","article-title":"Use of QuantiFERON-TB gold In-tube assay in screening for neutralizing anti-interferon-\u03b3 autoantibodies in patients with disseminated nontuberculous mycobacterial infection","volume":"24","author":"Wu","year":"2018","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"10.1016\/j.jiph.2025.102952_bib15","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/cid\/ciz786","article-title":"Natural history and evolution of Anti-Interferon-\u03b3 Autoantibody-Associated immunodeficiency syndrome in Thailand and the United States","volume":"71","author":"Hong","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.jiph.2025.102952_bib16","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.3201\/eid2206.151860","article-title":"Interferon-\u03b3 autoantibodies as predisposing factor for nontuberculous mycobacterial infection","volume":"22","author":"Valour","year":"2016","journal-title":"Emerg Infect Dis"}],"container-title":["Journal of Infection and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876034125003016?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876034125003016?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T14:41:08Z","timestamp":1772894468000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1876034125003016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":16,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S1876034125003016"],"URL":"https:\/\/doi.org\/10.1016\/j.jiph.2025.102952","relation":{},"ISSN":["1876-0341"],"issn-type":[{"value":"1876-0341","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical characteristics analysis of anti-interferon-\u03b3 autoantibodies-associated adult-onset immunodeficiency with mycobacterium tuberculosis infection","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Public Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiph.2025.102952","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences.","name":"copyright","label":"Copyright"}],"article-number":"102952"}}